• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 2 fuera de 14 páginas
Examen

Kettering (Special Procedures) Questions With Complete Solutions

Document preview thumbnail
Vista previa 2 fuera de 14 páginas

Kettering (Special Procedures) Questions With Complete Solutions Describe how the respiratory therapist would administer oxygen to a patient receiving hyperbaric oxygen therapy - ANSWER -- It is administered by mask or through the chamber at 100% Describe the purpose of utilizing Helium/Oxygen therapy for patients who have increased work of breathing (WOB) - ANSWER -- Decreases the patient's WOB by delivering low density gas (most important property) that can easily maneuver around obstructions State the indications of Helium/Oxygen therapy - ANSWER -- Post extubation stridor - Severe asthma/status asthmaticus - Obstructive tumors - Foreign object aspiration - Partial vocal cord paralysis List the two He/O₂ mixtures that are available - ANSWER -- 80% He/20% O₂ (most used) - 70% He/30% O₂ What type of oxygen administration device is used to deliver Helium/Oxygen therapy? - ANSWER -- Non-rebreathing mask What would the actual flow rate be if a 70/30 heliox mixture is used with an oxygen flowmeter set at a rate of 8 L/min? - ANSWER -- Actual Flow= indicated flow × factor Factors: a) 80/20 mixture: 1.8 (or use 2) b) 70/30 mixture: 1.6 Ex: Actual Flow = indicated flow × factor Actual flow = 8 L/min × 1.6 Actual flow = 12.8 L/min Describe the physiologic effects of Inhaled Nitric Oxide (iNO) on the pulmonary system - ANSWER --Inhaled Nitric Oxide (iNO) acts as a potent pulmonary vasodilator, which improves pulmonary blood flow and PaO₂, but does not affect systemic blood pressure. List the 4 indications for inhaled nitric oxide therapy - ANSWER -- Primary pulmonary hypertension - Refractory hypoxemia related to increased pulmonary artery pressure (PAP) - Increased pulmonary vascular resistance (PVR) - Right heart failure/Cor Pulmonale State the standard initial dose for iNO therapy - ANSWER -- 20-40 ppm (parts per million) * Start at 40ppm if given 2 choices. Describe the side effects that can occur during iNO therapy - ANSWER -- Methemoglobin (MetHb) levels may increase - Nitrogen Dioxide (NO₂) levels may increase and are toxic to body levels 10 ppm - Rebound pulmonary hypertension- occurs when the iNO is discontinued too rapidly What should the therapist do to avoid a rebound effect when discontinuing iNO therapy? - ANSWER -- Titrate the iNO dose to 20 ppm, then 10 ppm to, 5 ppm, then discontinue Identify the device that is used to deliver iNO therapy to mechanically ventilated patient. - ANSWER -- injector module and sample line added to ventilator circuit distal to humidifier and 24 inches after inspiratory limb Describe a thoracentesis - ANSWER -- A diagnostic and/or therapeutic procedural in which a needle is inserted into the chest to remove fluid from the pleural space. The most common pleural disorder that requires a thoracentesis is a: - ANSWER -- Pleural effusion List the three methods that can be used to identify the presence of a pleural effusion - ANSWER -1. Physical examination reveals flat or dull percussion notes, diminished breath sounds and tracheal shifts away from the site. 2. X-ray findings- lateral decubitus film shows concave upper border or a continual line from the diaphragm to the apices. 3. Ultrasound techniques State the most common position for the patient during the thoracentesis procedure - ANSWER -- Have the patient sitting up and leaning forward Describe the appearance of a transudate. - ANSWER -- Usually clear and has a light straw color - Transudate (clear) fluid is also called serous fluid. What is the most common type of pathology associated with transudate fluid? - ANSWER -- This type of fluid would be associated with congestive heart failure Purulent fluid can be described as a - ANSWER -pus-filled exudate What two things does mucopurulent fluid contain - ANSWER -1. Mucus 2. Pus exudate

Vista previa del contenido

Kettering (Special Procedures) Questions With
Complete Solutions

Describe how the respiratory therapist would administer oxygen to a patient
receiving hyperbaric oxygen therapy - ANSWER -- It is administered by mask or
through the chamber at 100%

Describe the purpose of utilizing Helium/Oxygen therapy for patients who have
increased work of breathing (WOB) - ANSWER -- Decreases the patient's WOB
by delivering low density gas (most important property) that can easily maneuver
around obstructions

State the indications of Helium/Oxygen therapy - ANSWER -- Post extubation
stridor
- Severe asthma/status asthmaticus
- Obstructive tumors
- Foreign object aspiration
- Partial vocal cord paralysis

List the two He/O₂ mixtures that are available - ANSWER -- 80% He/20% O₂
(most used)
- 70% He/30% O₂

What type of oxygen administration device is used to deliver Helium/Oxygen
therapy? - ANSWER -- Non-rebreathing mask

What would the actual flow rate be if a 70/30 heliox mixture is used with an
oxygen flowmeter set at a rate of 8 L/min? - ANSWER -- Actual Flow= indicated
flow × factor

Factors:
a) 80/20 mixture: 1.8 (or use 2)
b) 70/30 mixture: 1.6

, Ex: Actual Flow = indicated flow × factor
Actual flow = 8 L/min × 1.6
Actual flow = 12.8 L/min

Describe the physiologic effects of Inhaled Nitric Oxide (iNO) on the pulmonary
system - ANSWER --Inhaled Nitric Oxide (iNO) acts as a potent pulmonary
vasodilator, which improves pulmonary blood flow and PaO₂, but does not affect
systemic blood pressure.

List the 4 indications for inhaled nitric oxide therapy - ANSWER -- Primary
pulmonary hypertension

- Refractory hypoxemia related to increased pulmonary artery pressure (PAP)

- Increased pulmonary vascular resistance (PVR)

- Right heart failure/Cor Pulmonale

State the standard initial dose for iNO therapy - ANSWER -- 20-40 ppm (parts
per million)

* Start at 40ppm if given 2 choices.

Describe the side effects that can occur during iNO therapy - ANSWER --
Methemoglobin (MetHb) levels may increase
- Nitrogen Dioxide (NO₂) levels may increase and are toxic to body levels > 10
ppm
- Rebound pulmonary hypertension- occurs when the iNO is discontinued too
rapidly

What should the therapist do to avoid a rebound effect when discontinuing iNO
therapy? - ANSWER -- Titrate the iNO dose to 20 ppm, then 10 ppm to, 5 ppm,
then discontinue

Información del documento

Subido en
27 de febrero de 2025
Número de páginas
14
Escrito en
2024/2025
Tipo
Examen
Contiene
Preguntas y respuestas
$11.49

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
TheExamMaestro
3.6
(18)
Vendido
162
Seguidores
5
Artículos
3878
Última venta
2 días hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes